BioXcel Therapeutics, Inc. (BTAI) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.73 | +75.6% |
| 2024 | $-23.51 | +76.1% |
| 2023 | $-98.33 | -1561.0% |
| 2022 | $-5.92 | -46.2% |
| 2021 | $-4.05 | -6.9% |
| 2020 | $-3.79 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-5.73 | +75.6% |
| 2024 | $-23.51 | +76.1% |
| 2023 | $-98.33 | -1561.0% |
| 2022 | $-5.92 | -46.2% |
| 2021 | $-4.05 | -6.9% |
| 2020 | $-3.79 | — |